pI: 7.6253 |
Length (AA): 551 |
MW (Da): 64587 |
Paralog Number:
8169
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 2
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Populus kitakamiensis | Trans-cinnamate 4-monooxygenase | 505 aa | 23.7% | 528 aa | Compounds | References |
Rattus norvegicus | Thromboxane-A synthase | 533 aa | 21.7% | 507 aa | Compounds | References |
Rattus norvegicus | Cytochrome P450 2C23 | 494 aa | 31.9% | 527 aa | Compounds | References |
Rattus norvegicus | Cytochrome P450 3A1 | 504 aa | 23.3% | 477 aa | Compounds | References |
Rattus norvegicus | Cytochrome P450 1A2 | 513 aa | 26.3% | 533 aa | Compounds | References |
Canis familiaris | Cytochrome P450 2B11 | 494 aa | 33.7% | 499 aa | Compounds | References |
Rattus norvegicus | Cytochrome P450 2D3 | 500 aa | 31.8% | 513 aa | Compounds | References |
Rattus norvegicus | Cytochrome P450 1A1 | 524 aa | 25.3% | 494 aa | Compounds | References |
Oryctolagus cuniculus | Cytochrome P450 2B4 | 491 aa | 32.4% | 491 aa | Compounds | References |
Macaca fascicularis | Steroid 17-alpha-hydroxylase/17,20 lyase | 508 aa | 24.0% | 487 aa | Compounds | References |
Rattus norvegicus | Cytochrome P450 2A2 | 492 aa | 30.8% | 491 aa | Compounds | References |
Rattus norvegicus | Cytochrome P450 24A1 | 514 aa | 20.2% | 494 aa | Compounds | References |
Rattus norvegicus | Cytochrome P450 2E1 | 493 aa | 28.7% | 502 aa | Compounds | References |
Rattus norvegicus | Cytochrome P450 2D18 | 500 aa | 31.9% | 521 aa | Compounds | References |
Helianthus tuberosus | Trans-cinnamate 4-monooxygenase | 505 aa | 23.2% | 512 aa | Compounds | References |
Rattus norvegicus | Cytochrome P450 2D2 | 500 aa | 31.3% | 469 aa | Compounds | References |
Thlaspi arvense | Cytochrome P450 71B1 | 496 aa | 23.3% | 503 aa | Compounds | References |
Rattus norvegicus | Cytochrome P450 2B1 | 491 aa | 33.1% | 474 aa | Compounds | References |
Rattus norvegicus | Cytochrome P450 2D1 | 504 aa | 30.6% | 509 aa | Compounds | References |
Rattus norvegicus | Cytochrome P450 17A1 | 507 aa | 24.1% | 453 aa | Compounds | References |